[Immunologic therapy for glomerulonephritis with combined immunoadsorption and IVIG therapy].
Immunoadsorption is an improvement of extracorporeal therapy which differs from plasmapheresis. After plasma perfusion on a special adsorption filter the patient's plasma is reinfused. Meanwhile more than 270 immunoadsorptions have been performed. 7 patients with SLE and glomerulonephritis as well as 3 patients suffering from Wegener's vasculitis and glomerulonephritis had been treated with combined immunoadsorption and IVIG therapy. After three sessions of immunoadsorption (2-3 1 plasma filtrate) the patients received 10 g 7S-immunoglobulin infusions on three consecutive days. Patients with SLE and end-stage kidney involvement (2 patients) did not show any benefit by the above mentioned treatment regimen. Patients with Wegener's vasculitis and glomerulonephritis showed no significant improvement, except in one of three patients who showed a remarkable decrease in proteinuria. On the other hand, patients with SLE and "moderate" kidney involvement (short course of disease, no fixed structural changes) showed improvement on combined immunoadsorption and IVIG therapy.
Welcker
M
M
4. Medizinische Abteilung-Klinische Immunologie/Rheumatologie, Krankenhaus Bogenhausen, Lehrkrankenhaus der TU München.
Helmke
K
K
D000327:Adsorption; D005921:Glomerulonephritis / Q000628:therapy*; D014890:Granulomatosis with Polyangiitis / Q000628:therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous; D007167:Immunotherapy; D008180:Lupus Erythematosus, Systemic / Q000628:therapy; D010956:Plasmapheresis
D016756:Immunoglobulins, Intravenous